This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hwaseong-si, KR (2023)
- Seoul, KR (2023)
Company Filing History:
2 out of 148 
Years Active: 2023-2025
Title: Hyun Soo Ryu: Innovator in Immunostimulating IL-2 Analogs
Introduction
Hyun Soo Ryu is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 (IL-2) analogs. With a total of 3 patents to his name, Ryu's innovations are paving the way for advancements in immunotherapy.
Latest Patents
Ryu's latest patents focus on immunostimulating IL-2 analogs. One of his notable inventions involves modifications to interleukin-2 alpha receptors. Additionally, he has developed interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors. These advancements are crucial for enhancing the efficacy of immunotherapies.
Career Highlights
Hyun Soo Ryu is currently associated with Hanmi Pharm. Co., Ltd., where he continues to push the boundaries of medical research. His work has garnered attention for its potential to improve treatment options for various diseases.
Collaborations
Ryu collaborates with esteemed colleagues, including Euh Lim Oh and Sang Yun Kim. Their combined expertise contributes to the innovative research being conducted at Hanmi Pharm.
Conclusion
Hyun Soo Ryu's contributions to the field of immunology through his patents on IL-2 analogs highlight his role as a key innovator. His work not only advances scientific understanding but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile